| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Molina Arturo Md serves as a Chief Medical Officer at PTGX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 16 sells. Those positions are worth an estimated $8.8M at current prices.
Historically, Molina Arturo Md's trades have earned a below-average insider score of 32/100 across 9 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -93.3%.
The biggest single holding is PTGX (~$8.8M) as Chief Medical Officer. The recent filings there lean toward selling, a net 139,814 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 15,000 | $104.79 | $1,571,850.00 | -15.1% | +19.6% | - | |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 23,151 | $82.30 | $1,905,305.42 | -21.6% | +18.6% | - | |
| Jan 20, 2026 | PTGX Protagonist Therapeutics, Inc. | Chief Medical Officer | Sell | 9,514 | $82.48 | $784,714.72 | -8.9% | +26.4% | - | |
| Nov 17, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 2,712 | $84.77 | $229,896.24 | -3.2% | -2.7% | - | |
| Jun 10, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sale+OE | 20,000 | $56.27 | $1,125,400.00 | -19.3% | -0.3% | +87.6% | |
| Mar 13, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sale+OE | 30,514 | $55.74 | $1,700,850.36 | -26.7% | +0.8% | +68.2% | |
| Jan 16, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 3,640 | $0.00 | - | -4.2% | +25.3% | +124.4% | |
| Nov 27, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sale+OE | 31,529 | $44.86 | $1,414,402.40 | -40.4% | -21.9% | +100.2% | |
| Nov 15, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 1,906 | $40.98 | $78,107.88 | -3.9% | -5.9% | +105.8% | |
| Nov 15, 2023 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 1,848 | $16.24 | $30,011.52 | -7.6% | +65.7% | +151.9% |